Cargando…

Percutaneous ethanol injection for hepatocellular carcinoma: 20-year outcome and prognostic factors

BACKGROUND: Ethanol injection is the best-known image-guided percutaneous ablation for hepatocellular carcinoma (HCC) and a well-tolerated, inexpensive procedure with few adverse effects. However, there have been few reports on its long-term results. AIMS: We report a 20-year consecutive case series...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiina, Shuichiro, Tateishi, Ryosuke, Imamura, Masatoshi, Teratani, Takuma, Koike, Yukihiro, Sato, Shinpei, Obi, Shuntaro, Kanai, Fumihiko, Kato, Naoya, Yoshida, Haruhiko, Omata, Masao, Koike, Kazuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2012
Materias:	Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466412/ https://www.ncbi.nlm.nih.gov/pubmed/22712520 http://dx.doi.org/10.1111/j.1478-3231.2012.02838.x

Ejemplares similares

Frequency, Risk Factors and Survival Associated with an Intrasubsegmental Recurrence after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Tateishi, Ryosuke, et al.
Publicado: (2013)

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
por: Shiina, Shuichiro, et al.
Publicado: (2012)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Machine-learning Approach for the Development of a Novel Predictive Model for the Diagnosis of Hepatocellular Carcinoma
por: Sato, Masaya, et al.
Publicado: (2019)

A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study
por: Yoshida, Hideo, et al.
Publicado: (2023)

Impact of IL28B Genetic Variation on HCV-Induced Liver Fibrosis, Inflammation, and Steatosis: A Meta-Analysis
por: Sato, Masaya, et al.
Publicado: (2014)

Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study
por: Ohki, Takamasa, et al.
Publicado: (2020)

Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
por: Asaoka, Yoshinari, et al.
Publicado: (2014)

IGF-II Producing Hepatocellular Carcinoma Treated with Sorafenib: Metabolic Complications and a Foresight to Molecular Targeting Therapy to the IGF Signal
por: Okushin, Kazuya, et al.
Publicado: (2012)

Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
por: Tateishi, Ryosuke, et al.
Publicado: (2014)

Infectious complications related to radiofrequency ablation of liver tumors: The role of antibiotics
por: Nakagomi, Ryo, et al.
Publicado: (2021)

Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma
por: Fujiwara, Naoto, et al.
Publicado: (2013)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

The Effectiveness of Liraglutide in Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Compared to Sitagliptin and Pioglitazone
por: Ohki, Takamasa, et al.
Publicado: (2012)

Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
por: Shiina, Shuichiro, et al.
Publicado: (2018)

Serum levels of ferritin do not affect the prognosis of patients with hepatocellular carcinoma undergoing radiofrequency ablation
por: Uchino, Koji, et al.
Publicado: (2018)

Receptor for Activated Protein Kinase C: Requirement for Efficient MicroRNA Function and Reduced Expression in Hepatocellular Carcinoma
por: Otsuka, Motoyuki, et al.
Publicado: (2011)

Improved prognosis of hepatitis C‐related hepatocellular carcinoma in the era of direct‐acting antivirals
por: Fukumoto, Tsuyoshi, et al.
Publicado: (2022)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial
por: Sato, Masaya, et al.
Publicado: (2023)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Phase I study on the safety, pharmacokinetic profile, and efficacy of the combination of TSU-68, an oral antiangiogenic agent, and S-1 in patients with advanced hepatocellular carcinoma
por: Ikeda, Masafumi, et al.
Publicado: (2014)

Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
por: Omata, Masao, et al.
Publicado: (2017)

In vivo Adenovirus‐mediated Prodrug Gene Therapy for Carcinoembryonic Antigen‐producing Pancreatic Cancer
por: Ohashi, Makoto, et al.
Publicado: (1998)

Immune checkpoint inhibitor in liver cancer—unique regional differences
por: Obi, Shuntaro, et al.
Publicado: (2020)

Clinical features of cardiac nodularity-like appearance induced by Helicobacter pylori infection
por: Nishizawa, Toshihiro, et al.
Publicado: (2020)

Endoscopic diagnosis for colorectal sessile serrated lesions
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Risk Factors for Prolonged Hospital Stay after Endoscopy
por: Nishizawa, Toshihiro, et al.
Publicado: (2021)

Proton Beam Therapy versus Radiofrequency Ablation for Patients with Treatment-Naïve Single Hepatocellular Carcinoma: A Propensity Score Analysis
por: Sekino, Yuta, et al.
Publicado: (2022)

Utility of hepatic vein waveform and transient elastography in patients with Budd–Chiari syndrome who require angioplasty: Two case reports
por: Nakatsuka, Takuma, et al.
Publicado: (2019)

Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma
por: Kumar, Vinod, et al.
Publicado: (2012)

Single small-interfering RNA expression vector for silencing multiple transforming growth factor-β pathway components
por: Jazag, Amarsanaa, et al.
Publicado: (2005)

Successful local treatment for repeated hepatic recurrences of cholangiolocellular carcinoma: a report on a long-term survivor
por: Shinohara, Kentaro, et al.
Publicado: (2017)

Safety of Regular-Dose Imatinib Therapy in Patients with Gastrointestinal Stromal Tumors Undergoing Dialysis
por: Niikura, Ryota, et al.
Publicado: (2016)

In-hospital mortality associated with transcatheter arterial embolization for treatment of hepatocellular carcinoma in patients on hemodialysis for end stage renal disease: a matched-pair cohort study using a nationwide database
por: Sato, Masaya, et al.
Publicado: (2019)

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors
por: Yamada, Tomoharu, et al.
Publicado: (2022)

Kyoto classification in patients who developed multiple gastric carcinomas after Helicobacter pylori eradication
por: Sakitani, Kosuke, et al.
Publicado: (2020)

Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs
por: Kishikawa, Takahiro, et al.
Publicado: (2013)

Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18)
por: Mikoshiba, Naoko, et al.
Publicado: (2012)

Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma
por: Enooku, Kenichiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vooaom9t2ioo17bihvub4h6bm7